headlinez.news Live news trend intelligence
◼ Archived Business 🔮 headlinez.news predicts: fades by tomorrow — graded ✓ correct

Versant agrees to buy golf simulator company Full Swing for $530 million

Versant is set to acquire golf simulator company Full Swing in a transaction valued at $530 million.

10sources
10articles
8velocity
+0%since first seen
46d agofirst detected
Visual summary for Versant agrees to buy golf simulator company Full Swing for $530 million
headlinez.news visual summary

📍 The outcome

The transaction transferred ownership from Bruin Capital to Versant, expanding its portfolio in interactive sports technology. No further updates on integration or operational changes were reported after the announcement.

Epilogue added 44d ago, after coverage quieted.

Momentum

How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →

The story so far

Versant has reached an agreement to purchase Full Swing, a company specializing in golf and sports technology. The deal involves the acquisition of the firm from its current owner, Bruin Capital.

Coverage from Stock Titan, Sports Business Journal, TradingView, The Hollywood Reporter, and CNBC focuses on the $530 million valuation. Outlets highlight the integration of Full Swing's interactive sports technology into Versant's existing platform.

Future developments will depend on the closing of the deal. Coverage does not yet specify a projected completion date or details regarding organizational restructuring.

Synthesized by headlinez.news from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 46d ago.

Who reported it (10)

The obvious questions

What is the value of the acquisition?

The acquisition is valued at $530 million.

Who is the seller in this transaction?

Full Swing is being acquired from Bruin Capital.

What is the primary business of Full Swing?

Full Swing produces golf simulators and interactive sports technology.

Topics

From around our network

Related trends

◼ Archived Business 🔮 holds ✗

Argenx to Buy Forte Biosciences for $2.2 Billion

A $2.2 billion acquisition agreement marks a significant shift in the immunology market, as Argenx moves to absorb Forte Biosciences.

10 sources 10 articles v 8 25d ago